QQ客服 官方微博 反馈留言

	Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis
	Cao, Yajuan; Li, Yan; Zhu, Weikang; Chen, Wanqing; Wu, Jianchun; Hou, Guozhen
刊名	DISEASE MARKERS
	2019
ISSN号	0278-0240
URL标识	查看原文
语种	英语
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/3628495
专题	上海中医药大学
推荐引用方式 GB/T 7714	Cao, Yajuan,Li, Yan,Zhu, Weikang,et al. Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis[J]. DISEASE MARKERS,2019.
APA	Cao, Yajuan,Li, Yan,Zhu, Weikang,Chen, Wanqing,Wu, Jianchun,&Hou, Guozhen.(2019).Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis.DISEASE MARKERS.
MLA	Cao, Yajuan,et al."Prognostic Value of BIRC5 in Lung Adenocarcinoma Lacking EGFR, KRAS, and ALK Mutations by Integrated Bioinformatics Analysis".DISEASE MARKERS (2019).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。